Skip to main content
Admissions guidance, study banks, and career tools — get started on Shalyam
Research News

Why Diabetic Wounds Refuse to Heal: New Insights

Mayur Tembhare
  1. million people worldwide are affected by chronic diabetic ulcers.

  2. Diabetic wounds cost around $755 billion each year to treat.

  3. Immune cells play a central role in coordinating the body's response to injury.

  4. Monocytes and macrophages receive particular attention in the review.

Why Diabetic Wounds Refuse to Heal: New Insights

Topic: Health

Scientists have found that immune cells play a key role in healing diabetic wounds. In normal healing, these cells help inflammation subside and tissue repair begin. But in diabetic wounds, this process breaks down.

Chronic diabetic ulcers are one of the most difficult complications facing modern healthcare. More than 131 million people worldwide are affected, and the wounds cost around $755 billion each year to treat.

Immune cells play a central role in coordinating the body's response to injury. However, previous research has often paid less attention to how different immune cell populations change over time as diabetic wounds progress through different stages of healing.

A recent review by Yi Ru and colleagues examines this issue in detail. They looked at how a wide range of immune cells behave throughout the wound healing process. The researchers focused on where these cells appear during different stages of healing and how diabetes can disrupt their normal behavior.

Monocytes and macrophages receive particular attention. During normal healing, monocytes move into damaged tissue and develop into macrophages. These macrophages typically shift from pro-inflammatory M1 states toward pro-reparative M2 states, allowing inflammation to subside and tissue repair to move forward. In diabetic wounds, however, this transition can break down.

Neutrophils and mast cells also contribute to healing by releasing substances that influence blood vessel permeability and help recruit additional cells to the wound. But in diabetic wounds, their activity is poorly regulated, prolonging inflammation and damaging tissue.

Dendritic cells may fail to clear cellular debris in diabetic wounds. This process normally removes dead cells, but when it's impaired, dead material can accumulate and continue triggering inflammatory signals.

T cells help control inflammation and repair by regulating the immune response. But in diabetic wounds, both the number and function of these cells can decline, slowing down healing.

Why It Matters

Understanding why diabetic wounds refuse to heal is crucial for developing effective treatments. This knowledge could lead to new therapies that improve wound management and reduce healthcare costs.

Key Facts

  • 131 million people worldwide are affected by chronic diabetic ulcers.
  • Diabetic wounds cost around $755 billion each year to treat.
  • Immune cells play a central role in coordinating the body's response to injury.
  • Monocytes and macrophages receive particular attention in the review.
  • Dendritic cells may fail to clear cellular debris in diabetic wounds.

Key Terms

Macrophage
A type of immune cell that helps clean up damaged tissue.
M1/M2 polarization model
A theory explaining how macrophages change from pro-inflammatory to pro-reparative states.

Implications

Understanding why diabetic wounds refuse to heal is crucial for developing effective treatments. This knowledge could lead to new therapies that improve wound management and reduce healthcare costs.

Source: https://www.sciencedaily.com/releases/2026/10/261006234534.htm

Journal reference:

  1. Yi Ru, Yunxi Cai, Guangyuan Cheng, Xiaoxuan Ma, Jingsi Jiang, Jiankun Song, Ying Luo, Ying Zhang, Qi Zheng, Mingxia Wang, Chunjie Gao, Bin Li, Le Kuai, Yue Luo, Zhan Zhang. Immune cells in diabetic wound repair: the key to better wound management. MedScience, 2025; 19 (6): 950 DOI: 10.1007/s11684-025-1190-y

Leave a comment

← All research

Get Exclusive Insights with Every Issue

Join Shalyam Newsletter

Stay ahead in education, research, and innovation—straight to your inbox.